BR112013025766A2 - desvenlafaxine modified release pharmaceutical compositions - Google Patents

desvenlafaxine modified release pharmaceutical compositions

Info

Publication number
BR112013025766A2
BR112013025766A2 BR112013025766A BR112013025766A BR112013025766A2 BR 112013025766 A2 BR112013025766 A2 BR 112013025766A2 BR 112013025766 A BR112013025766 A BR 112013025766A BR 112013025766 A BR112013025766 A BR 112013025766A BR 112013025766 A2 BR112013025766 A2 BR 112013025766A2
Authority
BR
Brazil
Prior art keywords
desvenlafaxine
pharmaceutical compositions
modified release
release pharmaceutical
modified
Prior art date
Application number
BR112013025766A
Other languages
Portuguese (pt)
Inventor
Ashok Kumar Sahoo
Makrand Avachat
Shrenik Kole
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of BR112013025766A2 publication Critical patent/BR112013025766A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

abstract not avaibleabstract not avaible

BR112013025766A 2011-04-12 2012-04-11 desvenlafaxine modified release pharmaceutical compositions BR112013025766A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN530KO2011 2011-04-12
PCT/IB2012/051761 WO2012140577A1 (en) 2011-04-12 2012-04-11 Modified release pharmaceutical compositions of desvenlafaxine

Publications (1)

Publication Number Publication Date
BR112013025766A2 true BR112013025766A2 (en) 2016-12-20

Family

ID=46062650

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013025766A BR112013025766A2 (en) 2011-04-12 2012-04-11 desvenlafaxine modified release pharmaceutical compositions

Country Status (5)

Country Link
KR (1) KR20140030156A (en)
AU (1) AU2012241407B2 (en)
BR (1) BR112013025766A2 (en)
MX (1) MX2013011884A (en)
WO (1) WO2012140577A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104352469A (en) * 2014-11-20 2015-02-18 哈尔滨圣吉药业股份有限公司 Desvenlafaxine succinate sustained-release tablets and preparation method thereof
TR201820634A2 (en) * 2018-12-27 2020-07-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF DESVENLAFAXINE

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US6197828B1 (en) 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
DK1466889T3 (en) 1999-04-06 2008-09-08 Sepracor Inc O-desmethylvenlafaxine succinate
ATE369330T1 (en) 2001-02-12 2007-08-15 Wyeth Corp O-DESMETHYL-VENLAFAXINE SUCCINATE SALT
JP4445853B2 (en) 2002-06-10 2010-04-07 ワイス エルエルシー Novel O-desmethylvenlafaxine formate
BRPI0507372A (en) 2004-02-06 2007-07-10 Wyeth Corp o-desmethylvenlafaxine (odv) multiparticulate formulation, methods for treating depression in a patient in need thereof and for reducing the gastrointestinal side effects of venlafaxine in a patient, modified multiparticulate release formulation, method for reducing side effects odv in a patient, modified-release venlafaxine product, methods to reduce gastrointestinal side effects associated with venlafaxine treatment, and to release odv in a pediatric or geriatric patient, odv and / or succinate multiparticulate formulations delayed release of odv formate or succinate, use of a formulation, and pharmaceutical package
EP1863464B1 (en) * 2005-03-31 2009-11-11 Wyeth O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof
EP1904040A2 (en) 2005-07-15 2008-04-02 Wyeth Highly bioavailable oral delayed release dosage forms of o-desmethylvenlafaxine succinate
US7820716B2 (en) 2007-01-08 2010-10-26 Mai De Ltd Crystalline polymorphs of desvenlafaxine succinate and their preparations
CA2692738A1 (en) 2007-07-12 2009-01-15 Dr. Reddy's Laboratories, Ltd. O-desmethylvenlafaxine
WO2009017813A1 (en) 2007-08-02 2009-02-05 Teva Pharmaceutical Industries Ltd. O-desmethyl venlafaxine saccharinate
CA2702664A1 (en) * 2007-10-16 2009-04-23 Alphapharm Pty Ltd Controlled-release pharmaceutical formulation
US20110046231A1 (en) 2007-10-22 2011-02-24 Actavis Group Ptc Ehf Solid forms of (±)-o-desmethylvenlafaxine salts
EP2085377A1 (en) 2008-01-29 2009-08-05 LEK Pharmaceuticals D.D. Novel salts of O-desmethyl-venlafaxine
KR100965527B1 (en) 2008-05-08 2010-06-23 제일약품주식회사 4-2-dimethylamino-1-1-hydroxycyclohexylethylphenoxyphosphate or pharmaceutically acceptable salt thereof, preparation method thereof and composition for the the prevention and treatment of central nervous system disease containing the same as an active ingredient
KR20100132069A (en) 2008-06-16 2010-12-16 테바 파마슈티컬 인더스트리즈 리미티드 Solid states of o-desmethylvenlafaxine salts

Also Published As

Publication number Publication date
AU2012241407A1 (en) 2013-05-02
KR20140030156A (en) 2014-03-11
MX2013011884A (en) 2013-11-21
NZ609568A (en) 2015-10-30
AU2012241407B2 (en) 2015-02-05
WO2012140577A1 (en) 2012-10-18

Similar Documents

Publication Publication Date Title
BR112013028281A2 (en) nampt inhibiting compounds and compositions
SMT201600350B (en) PHARMACEUTICAL COMPOSITIONS
BR112014003052A2 (en) pharmaceutical compositions
DK2694038T3 (en) PHARMACEUTICAL COMPOSITION
BR112013028512A2 (en) capsule
BR112014001219A2 (en) perfume
CO6970594A2 (en) Hemostatic compositions
DK3181128T3 (en) NILOTINIB PHARMACEUTICAL COMPOSITION
CO6980625A2 (en) Compositions that generate peracids
CO6930367A2 (en) Pharmaceutical compositions
DK3246018T3 (en) PHARMACEUTICAL COMPOSITION
DK3513803T3 (en) Hemostatic compositions
UY33906A (en) HERBICIDE COMPOSITIONS THAT INCLUDE TOPRAMEZONA
BR112013025866A2 (en) low viscosity formulations
EE201300005A (en) Pharmaceutical composition
BR112013028039A2 (en) cement composition
DK2897594T3 (en) PHARMACEUTICAL COMPOSITION
BR112013028251A2 (en) polypeptide
BR112013026462A2 (en) foot protector
ES2721400T8 (en) Diclofenac composition
CO6801722A2 (en) Pharmaceutical compositions
CU24163B1 (en) TYPICAL OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB
CO7010828A2 (en) Pharmaceutical preparation comprising substituted ßcyclodextrin
BR112013027222A2 (en) extended release composition containing peptides as active ingredient
BR112012029461A2 (en) solifenacin-containing pharmaceutical composition

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]